Jia Lu Wu
Direttore/Membro del Consiglio presso Chengdu Aixing Biotech Co. Ltd.
Posizioni attive di Jia Lu Wu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Chengdu Aixing Biotech Co. Ltd.
 Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Direttore/Membro del Consiglio | - | - |
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jia Lu Wu
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Director/Board Member | 2 |
Settori
| Technology Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Technology Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
- Borsa valori
- Insiders
- Jia Lu Wu
- Esperienza
